Does gender matter in glioblastoma?

Clinical and Translational Oncology

Volumn 13, Issue 10, 2011, Pages 737-741

  Verger, Eugènia ^a   Valduvieco, Izaskun ^a   Caral, Lluís ^a   Pujol, Teresa ^a   Ribalta, Teresa ^a   Viñolas, Núria ^a   Boget, Teresa ^a   Oleaga, Laura ^a   Blanco, Yolanda ^a   Graus, Francesc ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Gender; Glioblastoma; KPS; Prognostic factors; Radiotherapy

Indexed keywords

ADOLESCENT; AGED; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL TIME; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 81255165924     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0725-7     Document Type: Review

References (14)

1. R. Stupp W.P. Mason M.J. van den Bent, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 15758009 10.1056/NEJMoa043330 1:CAS:528:DC%2BD2MXit1Wksbk%3D (Pubitemid 40349501)
2. R. Stupp M.E. Hegi W.P. Mason, et al. 2009 Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 459 466 19269895 10.1016/S1470-2045(09)70025-7 1:CAS:528:DC%2BD1MXlsVKhs74%3D
3. H. Ohgaki P. Dessen B. Jourde, et al. 2004 Genetic pathways to glioblastoma: a population-based study Cancer Res 64 6892 6899 15466178 10.1158/0008-5472.CAN-04-1337 1:CAS:528:DC%2BD2cXotFalsrc%3D (Pubitemid 39330996)
4. L. Paszat N. Laperriere P. Groome, et al. 2001 A population-based study of glioblastoma multiforme Int J Radiat Oncol Biol Phys 51 100 107 11516858 1:STN:280:DC%2BD3MvntF2mug%3D%3D (Pubitemid 32758868)
5. M.J. Winger D.R. Macdonald J.G. Cairncross 1989 Supratentorial anaplastic gliomas in adults The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71 487 493 1:STN:280:DyaK3c%2FhtFaqsg%3D%3D
6. P. Kleihues W.K. Cavenee B.W. Scheithauer, et al. 2002 World Health Organization classification of tumours: pathology and genetics of tumours of the nervous system J Neuropathol Exp Neurol 61 215 225 11895036
7. D.R. Macdonald T.L. Cascino S.C. Schold Jr. J.G. Cairncross 1990 Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1277 1280 2358840 1:STN:280:DyaK3c3ptlyitQ%3D%3D (Pubitemid 20195640)
8. S.M. Chang F.G. Barker 2nd 2005 Marital status, treatment, and survival in patients with glioblastoma multiforme: a population based study Cancer 104 1975 1984 16130137 10.1002/cncr.21399 (Pubitemid 41513183)
9. M. Weller J. Felsberg C. Hartmann, et al. 2009 Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network J Clin Oncol 27 5743 5750 19805672 10.1200/JCO.2009.23.0805 1:CAS:528: DC%2BC3cXhtVWisbg%3D
10. G. Filippini C. Falcone A. Boiardi, et al. 2008 Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma Neuro Oncol 10 79 87 17993634 10.1215/15228517-2007-038 (Pubitemid 351250903)
11. S.M. Chang I.F. Parney W. Huang, et al. 2005 Glioma Outcomes Project Investigators Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293 557 564 1:CAS:528:DC%2BD2MXhtVWqsL4%3D
12. M. Caloglu V. Yurut-Caloglu H. Karagol, et al. 2009 Prognostic factors other than the performance status and age for glioblastoma multiforme A singleinstitutional experience. J BUON 14 211 218 1:STN:280: DC%2BD1MrjtVamsA%3D%3D
13. J.F. Reavey-Cantwell R.I. Haroun M. Zahurak, et al. 2001 The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature J Neurooncol 55 195 204 11859975 10.1023/A:1013845004294 1:STN:280:DC%2BD387isFGhsg%3D%3D (Pubitemid 34134044)
14. M.A. Brockmann A. Giese K. Mueller, et al. 2007 Preoperative thrombocytosis predicts poor survival in patients with glioblastoma Neuro Oncol 9 335 342 17504931 10.1215/15228517-2007-013 (Pubitemid 47169666)